Morrell Martha 4
4 · NeuroPace Inc · Filed Mar 4, 2026
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Morrell Martha
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
[F1][F2]2025-12-15$15.97/sh−25,000$399,250→ 49,964 total - Tax Payment
Common Stock
[F3]2026-03-03$13.83/sh−1,340$18,532→ 48,624 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
- [F3]Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
Signature
/s/ Leah Akin, Attorney-in-Fact|2026-03-04